Taken together, ADCY8, CDH8, and ZNF582 promoter methylation are promising predictive and prognostic biomarkers for multiple tumor types crossing geographic and racial boundaries that undeniably merits further validation. The gene discussed is CDH8; the disease is neoplasm.